Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2013
11/14/2013US20130302339 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and or wnt
11/13/2013EP2662367A1 Novel indole or indazole derivative or salt thereof
11/13/2013EP2662357A1 Novel bicyclic compound or salt thereof
11/13/2013EP2661308A1 Hypotonic aqueous composition with reduced chloride content, with or without phospholipids
11/13/2013EP2661282A1 A pharmaceutical composition of a complex of an anti-dig antibody and digoxigenin that is conjugated to a peptide
11/13/2013EP2661181A1 Food composition made of an algae extract for treating and/or preventing diabetic retinopathy
11/13/2013CN1750839B Administration of capsaicinoids
11/13/2013CN103391936A Anticancer agent
11/13/2013CN103391934A Dipyridylamine derivative
11/13/2013CN103387927A Fruit vinegar for clearing away summer heat and preparation method thereof
11/13/2013CN103386138A MicroRNA regulating cilium development, and application thereof
11/13/2013CN103386066A Medicine used for treating hernia and preparation method thereof
11/13/2013CN103385977A Immunization functional nasal ointment
11/13/2013CN103385923A Medicine for treating rheumatoid arthritis and preparation method thereof
11/13/2013CN102657833B Traditional Chinese medicine combination for treating puerperium fever
11/13/2013CN102655866B Therapeutic or prophylactic agent for diabetes
11/13/2013CN102423402B Traditional Chinese drug composition for treating night sweat
11/12/2013US8580857 Methods and compositions to determine the chemosensitizing dose of suramin used in combination therapy
11/12/2013US8580563 Placental stem cells
11/12/2013US8580557 Casein hydrolyzate, process for producing the same and use thereof
11/12/2013CA2714357C Mutations in neuronal gene sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus
11/12/2013CA2565250C Cysteamines for treating complications of hypercholesterolemia and diabetes
11/12/2013CA2537093C Compound capable of binding s1p receptor and pharmaceutical use thereof
11/12/2013CA2448022C Compositions for protein delivery via the pulmonary route
11/07/2013WO2013166366A1 Cul4b as predictive biomarker for cancer treatment
11/07/2013WO2013165800A1 2α-METHYL-19-NOR-(20S)-1α,25-DIHYDROXYVITAMIN D3 (2AMD) OR 2-METHYLENE-19-NOR-(20S)-1α,25-DIHYDROXYVITAMIN D3 (2MD) SUPPORT SURVIVAL AND FUNCTION OF TRANSPLANTED ISLET CELLS IN TYPE 1 DIABETES
11/07/2013US20130296404 Promoters Exhibiting Endothelial Cell Specificity and Methods of Using Same
11/07/2013US20130296337 Flashmelt oral dosage formulation
11/07/2013US20130295078 Method of improving absorption of vitamin e by a pet animal
11/07/2013US20130295050 Anti-igf-i receptor antibodies, dnas, vectors, host cells and genetic constructs
11/07/2013US20130295009 Method of treating inflammation
11/06/2013EP2659898A1 Interferon production-inducing agent containing lactic acid bacteria
11/06/2013EP2659896A2 Electricity-generating particulates and the use thereof
11/06/2013EP2659892A1 Concomitant drug for improving cognitive function
11/06/2013CN103384527A Ppar活化剂 Ppar activator
11/06/2013CN103382206A Quinoline or quinazoline derivative, its preparation method and application in medicines
11/06/2013CN103381241A Heat-dropping summer-heat-relieving refreshing liquor
11/06/2013CN103381150A Pharmaceutical composition and application thereof
11/06/2013CN102805822B Health care product for alleviating snoring
11/06/2013CN102552854B Moxibustion drops and preparation method thereof
11/06/2013CN102516364B Active peptide for simulating porcine growth hormone-like effect, preparation method for active peptide and application of active peptide
11/06/2013CN102196810B Pharmaceutical composition improved in absorption through intestinal tract
11/06/2013CN102171221B Novel fused aminodihydrothiazine derivative
11/06/2013CN102137853B Glucosyltransferase inhibitor comprising epigallocatechin gallate polymer as active ingredient
11/06/2013CN102038932B Metal-binding compounds and uses therefor
11/06/2013CN101835892B CDCA1 peptide and pharmaceutical agent comprising the same
11/06/2013CN101484391B Method for activating and stabilizing dissolved hydrogen in water
11/06/2013CN101361723B Improved pharmaceutical compositions
11/06/2013CN101267815B Metal-beta-lactamase inhibitor
11/05/2013US8575204 Nicotinamide derivates useful as P38 inhibitors
11/05/2013US8575149 5HT2C receptor modulators
11/05/2013US8575147 Spontaneously dispersible N-benzoyl staurosporine compositions
11/05/2013US8575113 BIR domain binding compounds
11/05/2013US8575109 Recombinant pokeweed antiviral proteins, compositions and methods related thereto
11/05/2013US8575088 Method of preventing acute or sub-acute hepatic failure by administering a long-acting recombinant human soluble tumor necrosis factor alpha receptor II fusion protein
11/05/2013CA2752865C Quickly soluble oral film dosage containing steviosides as a unpleasant taste masking agent
11/05/2013CA2690395C Use of bi-specific antibodies for pre-targeting diagnosis and therapy
11/05/2013CA2512673C 2-o sulfatase compositions and related methods
11/05/2013CA2491994C Modulators of the glucocorticoid receptor
11/05/2013CA2461305C Methods of suppressing microglial activation and systemic inflammatory responses
10/2013
10/31/2013WO2013163258A1 Microrna compounds and methods for modulating mir-21 activity
10/31/2013WO2013162382A1 Method for detoxification or measurement of at least one compound or at least one fluid in a host body
10/31/2013WO2013162078A1 Therapeutic agent for injury in epithelium and endothelium
10/31/2013WO2013162061A1 Bicyclic pyrimidine compound
10/31/2013WO2013162054A1 Composition for controlling chromatin structure
10/31/2013WO2013162047A1 Therapeutic agent for secondary hyperparathyroidism
10/31/2013WO2013162027A1 Neuronal differentiation promoter
10/31/2013WO2013161980A1 Cyclohexanediamide derivative and use thereof for medical purposes
10/31/2013WO2013161929A1 Pyridinyl morpholinone derivative and drug composition containing same
10/31/2013WO2013161928A1 Oxazolotriazole derivative and drug composition containing same
10/31/2013WO2013161919A1 Trk-INHIBITING COMPOUND
10/31/2013WO2013161913A1 Nitrogenated heterocyclic compound
10/31/2013WO2013161904A1 Sulfonamide derivative and medicinal use thereof
10/31/2013WO2013161896A1 Sustained release carrier for drugs
10/31/2013WO2013161871A1 Thiophene derivative having tlr-inhibiting activity
10/31/2013WO2013161853A1 Quinazolinedione derivative
10/31/2013WO2013161851A1 Benzamide derivative
10/31/2013WO2013161848A1 Novel 1,2,4-triazine derivative
10/31/2013WO2013161821A1 Cgrp responsiveness promoter
10/31/2013WO2013161820A1 Composition for promoting bifidobacteria growth
10/31/2013WO2013161751A1 Composite particles and cell preparation prepared using same
10/31/2013WO2013161359A1 Enteral environment-improving agent
10/31/2013WO2013161312A1 Pyrrolopyridinone derivatives as ttx-s blockers
10/31/2013WO2013161308A1 Amide derivatives as ttx-s blockers
10/31/2013WO2013043085A8 (rs)-2-(2-oxo-4-phenylpyrrolidin-1-yl)acetamide compound which exhibits modulatory activity with a commensurate effect, pharmaceutical substance (variants) and use thereof, composition (variants)
10/31/2013WO2002078598A3 Peptides and antibodies to muc 1 proteins
10/31/2013US20130288999 Compositions and methods for modulation of vascular structure and/or function
10/31/2013US20130287725 Biocompatible polymers, process for their preparation and compositions containing them
10/31/2013DE59209330C5 Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Benzimidazoles, pharmaceutical compositions containing them and methods for their preparation
10/30/2013EP2657246A1 Modulator of activity of adenylate cyclase
10/30/2013EP2657241A1 Diphenyl sulfide derivative and pharmaceutical product which contains same as active ingredient
10/30/2013EP2657236A1 Novel 2-alkynyl-n9-propargyladenine and medicinal use thereof
10/30/2013EP2657234A1 Optically-active diazabicyclooctane derivative and method for manufacturing same
10/30/2013EP2657233A1 3,5-disubstituted alkynylbenzene compound and salt thereof
10/30/2013EP2657230A1 Amide derivative and use thereof
10/30/2013EP2656845A1 Composition for modulating stem cell growth with prostaglandins
10/30/2013EP2655295A1 Radioiodinated guanidines
10/30/2013EP2654897A1 Method for increasing embryo implantation rate in mother's uterus in mammals, use of an effective amount of beta - galactoside - binding lectin or derivatives thereof, beta - galactoside - binding lectin or derivatives and product.
10/30/2013CN103379906A Therapeutic agent for corneal sensory nerve damage containing semaphorin inhibitor as active ingredient
10/30/2013CN103374552A PHF 8 (Plant Homedomain Finger Protein 8) protein fragment as well as prokaryotic expression and purification method and antibody thereof
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 1564